switching from semaglutide to tirzepatide between weight-loss medications Switching from semaglutide to tirzepatide

Shauna Levy, a specialist in obesity medicine and the medical director of the Tulane Bariatric Center in New Orleans, are "mind-blowing." Levy, who was not involved with the research, said the drug seems to be delivering results that are approaching the effectiveness of bariatric surgery

See a review of weight regain after withdrawal in clinical cohorts here and a trajectory analysis in BMC Medicine

Call our office or request an appointment online to schedule your peptide therapy consultation in in Laurel, MD, Alexandria, VA and Washington D.C

doi: 10.1093/humrep/dev213 207 Eldar-GevaTHirschHJRabinowitzRBenarrochFRubinsteinOGross-TsurV

It has plausible biology and promising preclinical findings, but current human evidence does not show that it causes meaningful fat loss

JAMA Internal Medicine